Emergency surgery for lung cancer with abscess formation after transbronchial biopsy. Issue 2 (6th February 2017)

• Record Type: Journal Article
• Authors: Takanashi, Yusuke; Miyashita, Koichi; Tajima, Shogo; Hayakawa, Takamitsu; Neyatani, Hiroshi; Funai, Kazuhito
• Is Part Of: Respirology case reports. Volume 5:Issue 2(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-02-06
• Subjects: Abscess -- lung cancer -- transbronchial biopsy; Respiratory organs -- Diseases -- Periodicals; 616.2005
• DOI: 10.1002/rcr2.218
• Languages: English
• ISSNs: 2051-3380

Abstract

Abstract : Abscess formation in lung cancer after transbronchial biopsy (TBB) is a rare complication with no standard consensus on a coping strategy or prophylaxis. We describe an instructive case of lung cancer which developed into an abscess after TBB. An 80‐year‐old man with poorly controlled diabetes mellitus underwent TBB for diagnosing a mass lesion in the left upper lobe. The TBB specimen confirmed a diagnosis of lung cancer, and he was scheduled for radical surgery. However, the tumour was revealed to have progressed into an enlarged abscess 24 days after TBB. Prompt use of meropenem failed to relieve the infection, hence we performed emergency left upper lobectomy. Poorly controlled diabetes mellitus was considered to be a risk for the formation of a tumour abscess after TBB. It was difficult to control the infection with conservative treatment using antibiotics; emergency surgical resection was considered to be the safest strategy for recovery. Abstract : Abscess formation in lung cancer after transbronchial biopsy (TBB) is a rare complication with no standard consensus on a coping strategy or prophylaxis. We describe an instructive case of lung cancer that developed into an abscess after TBB in an 80‐year‐old man with poorly controlled diabetes mellitus. Prompt use of meropenem failed to relieve the infection, and we successfully performed emergency left upper lobectomy thereby achieving both infection control and radical treatment for cancer.